Alpha-Beta Thalassemia: Understanding Co-occurrence and Severity

Alpha-beta thalassemia (also called thalassemia intermedia when combined) occurs when an individual inherits mutations in both the alpha-globin (HBA1/HBA2) and beta-globin (HBB) genes. This double heterozygosity (or compound heterozygosity) creates a unique clinical picture.

Genetic Basis

• Normal: 4 alpha genes (αα/αα), 2 beta genes (β/β).
• Alpha thalassemia: Deletion/mutation of 1–4 alpha genes.
• Beta thalassemia: Mutation of 1–2 beta genes (β⁰ or β⁺).
• Co-inheritance: e.g., –α/αα (alpha trait) + β⁰/β (beta trait) → alpha-beta thalassemia.

Clinical Spectrum

• Mild (Asymptomatic to Mild Anemia): Single alpha gene deletion + beta trait. Hb 10–12 g/dL. Minimal symptoms.
• Moderate (Thalassemia Intermedia): Two alpha gene deletions + beta trait, or alpha trait + beta major mutation. Hb 7–10 g/dL. May need occasional transfusions, folic acid, monitoring for extramedullary hematopoiesis, leg ulcers, gallstones.
• Severe (Approaching Thalassemia Major): Rare combinations (e.g., HbH disease + beta mutation). Transfusion-dependent.

The severity depends on the net globin chain imbalance. Alpha mutations reduce alpha chains; beta mutations reduce beta chains. Co-inheritance can partially balance the excess of the other chain, sometimes ameliorating the phenotype compared to beta thalassemia alone.

Diagnosis

• CBC: Microcytic hypochromic anemia (low MCV, MCH), target cells, basophilic stippling.
• Hemoglobin Electrophoresis/HPLC: Elevated HbA₂ (>3.5% = beta trait), HbF; HbH inclusions (alpha).
• Genetic Testing: Alpha globin gene mapping (MLPA/GAP-PCR) + beta globin sequencing.

Management

• Folic acid 1 mg/day.
• Monitor Hb, growth, iron status (avoid iron overload unless deficient).
• Transfusions only if symptomatic anemia (not for number alone).
• Chelation if iron overloaded.
• Splenectomy if hypersplenism (cautiously—infection risk).
• Genetic counseling for family planning.

Specialized hematology care is essential. The interaction between alpha and beta defects creates a nuanced phenotype requiring individualized management.